Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7301 - 7325 of 13634 in total
Mito-4509 is a non-feminizing estrogen analog that could affect mitochondrial metabolic pathways. It is used to treat Parkinson's Disease, Alzheimer's Disease, Retinal Disorders and other neurologic Disorders.
Investigational
Matched Description: … Mito-4509 is a non-feminizing estrogen analog that could affect mitochondrial metabolic pathways. …
Chrysalin has been used in trials studying the treatment of Radius Fracture.
Investigational
Matched Description: … Chrysalin has been used in trials studying the treatment of Radius Fracture. …
Experimental
Matched Categories: … Antibacterials for Systemic Use ... Antiinfectives for Systemic Use …
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Matched Description: … Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic. …
5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS.
Experimental
Investigational
ZM-39923 is a small molecule that inhibits Janus kinase and human tissue transglutaminase (TGM2).
Investigational
Matched Description: … ZM-39923 is a small molecule that inhibits Janus kinase and human tissue transglutaminase (TGM2). …
Ozekibart is a tetravalent recombinant humanized IgG1 agonist antibody targeting the human TRAIL death receptor 5 (DR5). It is being investigated for the treatment of chondrosarcoma.
Investigational
Matched Description: … It is being investigated for the treatment of chondrosarcoma. ... Ozekibart is a tetravalent recombinant humanized IgG1 agonist antibody targeting the human TRAIL death …
Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
Investigational
Matched Description: … Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of …
ARX201 (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrx’s patented ReCODE™ technology to achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth hormone, by biosynthetic incorporation of a chemically unique amino acid (ahGH). ARX201 has improved pharmacological...
Investigational
Matched Description: … ARX201 (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrx’s ... site of polyethylene glycol (PEG) attachment to human growth hormone, by biosynthetic incorporation of a
Cloridarol is an experimental medication in the treatment of heart disease, which acts through vasodilation. It was studied for the treatment of coronary insufficiency in Italy in the 1970s .
Experimental
Matched Description: … It was studied for the treatment of coronary insufficiency in Italy in the 1970s [A176222]. ... Cloridarol is an experimental medication in the treatment of heart disease, which acts through vasodilation …
Matched Categories: … Vasodilators Used in Cardiac Diseases …
IPH-2101 (NN-1975), a fully human monoclonal antibody developed for patients with acute myeloid leukemia.
Investigational
Matched Description: … IPH-2101 (NN-1975), a fully human monoclonal antibody developed for patients with acute myeloid leukemia …
Ginkgo biloba leaf oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Ginkgo biloba leaf oil is a plant/plant extract used in some OTC (over-the-counter) products. …
Peginterferon lambda-1a is under investigation in clinical trial NCT01754974 (Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C).
Investigational
Matched Description: … Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C). ... Peginterferon lambda-1a is under investigation in clinical trial NCT01754974 (Safety and Efficacy Study …
Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2). This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.
Investigational
Matched Description: … This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune ... Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 …
Atractylodes japonica root oil is obtained from the roots of Atractylodes japonica, which is a herb native to eastern Asia. It is present in some cosmetic products such as whitening creams as an active ingredient and lubricant for skin irritation. Atractylodes japonica is reported to have anti-inflammatory and antinociceptive effects...
Experimental
Matched Description: … for skin irritation. ... Atractylodes japonica root oil is obtained from the roots of Atractylodes japonica, which is a herb native ... It is present in some cosmetic products such as whitening creams as an active ingredient and lubricant …
Virginiamycin is a streptogramin antibiotic similar to pristinamycin and quinupristin/dalfopristin. It is a combination of pristinamycin IIA and virginiamycin S1. Virginiamycin is used in the fuel ethanol industry to prevent microbial contamination and in livestock to prevent and treat infections. According to a USDA study, antibiotics can save as much...
Vet approved
Matched Description: … According to a USDA study, antibiotics can save as much as 30% in feed costs among young swine. ... Virginiamycin is used in the fuel ethanol industry to prevent microbial contamination and in livestock ... It is a combination of pristinamycin IIA and virginiamycin S1. …
Matched Categories: … Antibiotics for Topical Use …
VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications. It is being developed by Vitae Pharmaceuticals.
Investigational
Matched Description: … VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment …
PAC-113 an anti-fungal, for the treatment of oral candidiasis infections. It is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in saliva. In vitro studies demonstrate that it has potent anti-fungal activity against the Candida albicans, including drug-resistant HIV patient isolates. PAC-113 is targeting oral...
Investigational
Matched Description: … PAC-113 an anti-fungal, for the treatment of oral candidiasis infections. ... It is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found ... in saliva. …
QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies that is designed to enhance the body’s immune response to the antigen contained within the treatment. It is the leading member of the Stimulon family of adjuvants. As a vaccine additive, it is currently being...
Investigational
Matched Description: … As a vaccine additive, it is currently being evaluated in clinical trials in a variety of disease areas ... QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies …
NSI-189 is under investigation in clinical trial NCT02695472 (Study of NSI-189 for Major Depressive Disorder).
Investigational
Matched Description: … NSI-189 is under investigation in clinical trial NCT02695472 (Study of NSI-189 for Major Depressive Disorder …
Experimental
NN344 is a neutral, soluble long-acting human insulin analogue with 24 hour coverage by once daily injection. NN344 has a very flat and predictable action profile. The product is intended for basal insulin treatment of diabetes mellitus.
Investigational
Matched Description: … The product is intended for basal insulin treatment of diabetes mellitus. ... NN344 has a very flat and predictable action profile. ... NN344 is a neutral, soluble long-acting human insulin analogue with 24 hour coverage by once daily injection …
Displaying drugs 7301 - 7325 of 13634 in total